Y
Yinchao Li
Researcher at Nanjing Tech University
Publications - 5
Citations - 147
Yinchao Li is an academic researcher from Nanjing Tech University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 2, co-authored 3 publications receiving 50 citations.
Papers
More filters
Journal ArticleDOI
Odor emission and microbial community succession during biogas residue composting covered with a molecular membrane.
TL;DR: A membrane-covered composting system was used to investigate the odor emission and microbial community succession during biogas residue composting and results showed that in comparison with the control (CK) group, the NH3 and H2S emissions outside the membrane of the membrane- covered (CT) group decreased.
Journal ArticleDOI
Enhanced biogas production from swine manure anaerobic digestion via in-situ formed graphene in electromethanogenesis system
Yongdi Liu,Yinchao Li,Rong Gan,Honghua Jia,Xiaoyu Yong,Yang-Chun Yong,Xiayuan Wu,Ping Wei,Jun Zhou +8 more
TL;DR: In this article, an in-situ formed graphene in microbial electrolysis cell (AD-MEC) was used to enhance methane production from swine manure anaerobic digestion.
Journal ArticleDOI
Effect of biochar combined with a biotrickling filter on deodorization, nitrogen retention, and microbial community succession during chicken manure composting.
TL;DR: In this paper, the combined application of biochar and biotrickling filtration (BTF) to remove of odor in chicken manure mixed straw compost (w/w, 2.5:1) was evaluated.
Journal ArticleDOI
Carrier-free programmed spherical nucleic acid for effective ischemic stroke therapy via self-delivery antisense oligonucleotide
Wenyan Yu,Cui Xian Xuan,Bingbing Liu,Li Zhou,Na Yin,Enpeng Gong,Zhenzhong Zhang,Yinchao Li,Kaixiang Zhang,Jinjin Shi +9 more
TL;DR: It is demonstrated that the carrier-free programmed spherical nucleic acid nanostructure could significantly improve the therapeutic efficacy of ischemic stroke and was a promising therapeutic tool for various brain damage-related diseases.
Journal ArticleDOI
P2Y6R: a promising new target in inflammatory diseases and the advance of its antagonists.
TL;DR: The role of P2Y6R in inflammation is summarized and the anti-inflammatory mechanism of a key P2y6R antagonist is highlighted, MRS2578, a promising molecular target for the treatment of inflammatory diseases.